CA2287469C - Interactive system for presenting and eliminating substances - Google Patents
Interactive system for presenting and eliminating substances Download PDFInfo
- Publication number
- CA2287469C CA2287469C CA2287469A CA2287469A CA2287469C CA 2287469 C CA2287469 C CA 2287469C CA 2287469 A CA2287469 A CA 2287469A CA 2287469 A CA2287469 A CA 2287469A CA 2287469 C CA2287469 C CA 2287469C
- Authority
- CA
- Canada
- Prior art keywords
- substance
- interactive system
- blood
- peg
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/14—Dynamic membranes
- B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
- B01D69/1411—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes containing dispersed material in a continuous matrix
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/40—Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/40—Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
- B01D71/401—Polymers based on the polymerisation of acrylic acid, e.g. polyacrylate
- B01D71/4011—Polymethylmethacrylate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
- C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19715504A DE19715504C2 (de) | 1997-04-14 | 1997-04-14 | PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen |
DE19715504.9 | 1997-04-14 | ||
PCT/EP1998/002183 WO1998046648A1 (de) | 1997-04-14 | 1998-04-14 | Interaktionssystem zur präsentation und entfernung von substanzen |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2287469A1 CA2287469A1 (en) | 1998-10-22 |
CA2287469C true CA2287469C (en) | 2010-02-09 |
Family
ID=7826448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2287469A Expired - Fee Related CA2287469C (en) | 1997-04-14 | 1998-04-14 | Interactive system for presenting and eliminating substances |
Country Status (9)
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19845286A1 (de) * | 1998-10-01 | 2000-04-27 | Udo Dunzendorfer | Beschichtete Trägermaterialien für Blut-, Plasma- oder Gewebewäsche und mit diesen Trägermaterialien ausgerüstete Säulen |
DE19909584A1 (de) * | 1999-03-04 | 2000-09-14 | Haemosys Gmbh | Trennverfahren |
DE19915862A1 (de) * | 1999-04-08 | 2000-10-12 | Max Planck Gesellschaft | Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie |
DE19918569A1 (de) * | 1999-04-23 | 2000-12-07 | Haemosys Gmbh | Verfahren zur Diagnose von Krankheiten, pathologischen Zuständen und pathophysiologischen sowie physiologischen Messgrößen |
DE19955341A1 (de) * | 1999-11-17 | 2001-08-02 | Haemosys Gmbh | Blutkompatible Polymeroberflächen |
CA2404115A1 (en) * | 2000-03-20 | 2001-09-27 | Knoll Gmbh | The use of peg-hirudin as an anticoagulant agent in the extracorporeal treatment of blood |
KR100345323B1 (ko) * | 2000-04-24 | 2002-07-24 | 학교법인 포항공과대학교 | 나노 자성체 입자들을 포함하는 복합체 |
DE10162521A1 (de) * | 2001-12-19 | 2003-07-17 | Goetz Nowak | Verwendung von molekulargewichtserweiterten Substanzen in der Tumortherapie |
EP1443058A1 (en) * | 2003-01-29 | 2004-08-04 | Firmenich Sa | Polymeric particles and fragrance delivery systems |
DE10330900B4 (de) † | 2003-07-01 | 2006-09-14 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt |
EG23584A (en) * | 2003-11-11 | 2006-09-11 | Ali Mokhtar Al-Hossary Amr | Elimination of myoglobin from blood using an i v filter |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
DE102005001162A1 (de) * | 2005-01-10 | 2006-07-20 | Haemosys Gmbh | Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma |
WO2007053935A1 (en) | 2005-11-14 | 2007-05-18 | Universite De Montreal | Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
DE102007033787A1 (de) | 2007-07-09 | 2009-01-15 | Aesculap Ag | Gefäßprothese mit reduzierter Thrombogenität |
DE102008000220A1 (de) * | 2008-02-01 | 2009-08-13 | ASCALON Gesellschaft für Innovation in der Medizintechnik m.b.H. | Hohlfaser-Separationsmembranen und Verfahren zu ihrer Herstellung |
ES2620421T3 (es) | 2009-10-30 | 2017-06-28 | Senova Gesellschaft für Biowissenschaft und Technik mbH | Peptidasas acopladas a polímero |
EP2620162A1 (de) | 2012-01-27 | 2013-07-31 | Life Science Inkubator | Enzym-Polymer-Konjugat zur Endotoxin-Detoxifikation |
ES2747836T3 (es) * | 2012-09-06 | 2020-03-11 | Adelaide Research&Innovation Pty Ltd | Métodos y productos para prevenir y/o tratar el cáncer metastásico |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1603393A (US20050239131A1-20051027-C00001.png) * | 1967-12-27 | 1971-04-13 | ||
JPS4867382A (US20050239131A1-20051027-C00001.png) * | 1971-12-06 | 1973-09-14 | ||
GB1484564A (en) * | 1974-07-24 | 1977-09-01 | Koch Light Labor Ltd | Stable support material for enzyme insolubilisation |
FR2321520A1 (fr) * | 1975-08-22 | 1977-03-18 | Rhone Poulenc Ind | Latex de polymeres possedant des groupes-cn |
DE2552510C3 (de) | 1975-11-22 | 1981-02-19 | Behringwerke Ag, 3550 Marburg | Biologisch aktive Verbindungen und Verfahren zu ihrer Herstellung |
DE2712344C2 (de) | 1977-03-21 | 1982-09-23 | Hans Dr. 4803 Steinhagen Bünemann | Löslicher Komplexbildner für die affinitätsspezifische Trennung von Nukleinsäuren |
JPS57170263A (en) * | 1981-04-14 | 1982-10-20 | Kuraray Co | Absorber for blood protein |
US4575539A (en) * | 1985-06-03 | 1986-03-11 | E. R. Squibb & Sons, Inc. | Drug delivery systems including novel interpenetrating polymer networks and method |
JPH01310668A (ja) | 1988-06-09 | 1989-12-14 | Nikkiso Co Ltd | 中空糸型血液浄化装置 |
CA1335142C (en) | 1989-07-18 | 1995-04-04 | Leon Edward St-Pierre | Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol |
CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
SE467309B (sv) * | 1990-10-22 | 1992-06-29 | Berol Nobel Ab | Hydrofiliserad fast yta, foerfarande foer dess framstaellning samt medel daerfoer |
KR930702403A (ko) * | 1990-10-26 | 1993-09-09 | 라이오넬 엔. 사이몬 | 올리고머의 고체상 합성을 위한 비-방향족 유기 중합체 시약 |
JPH06256394A (ja) * | 1991-08-13 | 1994-09-13 | Kirin Amgen Delaware Inc | 修飾インターロイキン6 |
DE4203965A1 (de) | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Antidot fuer hirudin und synthetische thrombininhibitoren |
US5578442A (en) * | 1992-03-23 | 1996-11-26 | Vivorx, Inc. | Graft copolymers of polycationic species and water-soluble polymers, and use therefor |
DE4322884A1 (de) | 1992-10-09 | 1994-04-14 | Bayer Ag | Biologisch aktive Polymere |
US5414075A (en) * | 1992-11-06 | 1995-05-09 | Bsi Corporation | Restrained multifunctional reagent for surface modification |
AU689477B2 (en) * | 1993-04-27 | 1998-04-02 | Cytotherapeutics, Inc. | Membrane formed by an acrylonitrile-based polymer |
FR2724461B1 (fr) | 1994-09-09 | 1996-12-20 | Prolabo Sa | Microsphere de latex biotinylee, procede de preparation d'une telle microsphere et utilisation en tant qu'agent de detection biologique |
US5665428A (en) * | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
US5752974A (en) * | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
DE19625642A1 (de) | 1996-06-26 | 1998-01-08 | Max Planck Gesellschaft | Verfahren zur Herstellung einer Antidotausgangssubstanz für natürliche und synthetische Thrombininhibitoren |
-
1997
- 1997-04-14 DE DE19715504A patent/DE19715504C2/de not_active Expired - Fee Related
-
1998
- 1998-04-14 JP JP54349698A patent/JP4495258B2/ja not_active Expired - Fee Related
- 1998-04-14 EP EP98922710A patent/EP0975680B1/de not_active Expired - Lifetime
- 1998-04-14 DE DE59814134T patent/DE59814134D1/de not_active Expired - Lifetime
- 1998-04-14 EP EP07122292A patent/EP1921094A3/de not_active Withdrawn
- 1998-04-14 CA CA2287469A patent/CA2287469C/en not_active Expired - Fee Related
- 1998-04-14 AU AU75254/98A patent/AU7525498A/en not_active Abandoned
- 1998-04-14 ES ES98922710T patent/ES2297886T3/es not_active Expired - Lifetime
- 1998-04-14 AT AT98922710T patent/ATE380202T1/de active
- 1998-04-14 WO PCT/EP1998/002183 patent/WO1998046648A1/de active IP Right Grant
-
1999
- 1999-10-14 US US09/417,534 patent/US6929955B2/en not_active Expired - Fee Related
-
2005
- 2005-06-29 US US11/170,666 patent/US7494824B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4495258B2 (ja) | 2010-06-30 |
ATE380202T1 (de) | 2007-12-15 |
AU7525498A (en) | 1998-11-11 |
DE19715504A1 (de) | 1998-10-15 |
DE19715504C2 (de) | 2000-10-26 |
EP1921094A2 (de) | 2008-05-14 |
EP1921094A3 (de) | 2009-06-24 |
EP0975680A1 (de) | 2000-02-02 |
US7494824B2 (en) | 2009-02-24 |
JP2001527539A (ja) | 2001-12-25 |
EP0975680B1 (de) | 2007-12-05 |
US6929955B2 (en) | 2005-08-16 |
US20050239131A1 (en) | 2005-10-27 |
ES2297886T3 (es) | 2008-05-01 |
WO1998046648A1 (de) | 1998-10-22 |
CA2287469A1 (en) | 1998-10-22 |
US20020028201A1 (en) | 2002-03-07 |
DE59814134D1 (de) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7494824B2 (en) | Interactive system for presenting and eliminating substances | |
Mao et al. | Various approaches to modify biomaterial surfaces for improving hemocompatibility | |
CA2074730C (en) | Immobilized polyethylene oxide star molecules for bioapplications | |
US8048437B2 (en) | Medical device with surface coating comprising bioactive compound | |
CN102791307B (zh) | 通过体外疗法除去毒力因子 | |
WO1987006007A1 (fr) | Substance physiologiquement active immobilisee | |
KR19990043992A (ko) | 친화성 막 시스템 및 그의 사용 방법 | |
AU7671791A (en) | Gas permeable thrombo-resistant coatings and methods of manufacture | |
WO2004037310A2 (en) | Surface coating comprising bioactive compound | |
TW200820999A (en) | Substrate and manufacturing method thereof | |
JP2565363B2 (ja) | トロンボゲンを形成しない基質の製造方法 | |
Dang et al. | Heparin as a molecular spacer immobilized on microspheres to improve blood compatibility in hemoperfusion | |
CN114106493B (zh) | 一种肝素化pvc材料、其制备方法及作为医疗器械的应用 | |
Ishihara et al. | Improvement of blood compatibility on cellulose hemodialysis membrane: IV. Phospholipid polymer bonded to the membrane surface | |
US6746482B2 (en) | Method for producing medical devices and devices so produced | |
Baumann et al. | Surface modification of the polymers present in a polysulfone hollow fiber hemodialyser by covalent binding of heparin or endothelial cell surface heparan sulfate: flow characteristics and platelet adhesion | |
JP2003515110A (ja) | 血液適合性ポリマー表面 | |
WO1993014127A1 (en) | Method and composition for heparin binding using polyaminocations covalently immobilised on polymeric surfaces with polyethylene oxide spacers | |
Denizli et al. | Biologically modified PHEMA beads for hemoperfusion: preliminary studies | |
Abd El-Rehima | Hemodialysis membranes based on functionalized high-density polyethylene | |
JPH0623042A (ja) | 血液浄化吸着材および血液浄化方法 | |
JP2004201752A (ja) | タンパク吸着抑制材料およびそれを用いたカラム | |
JPH06121834A (ja) | 抗血小板抗体吸着材 | |
Wang | Design of a protamine bioreactor for extracorporeal heparin removal | |
JPH10147540A (ja) | 補体成分除去用あるいは不活化用の材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140415 |